Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences
We investigated early use of a special type of scan called PSMA PET (prostate-specific membrane antigen positron emission tomography) in patients with suspicion of recurrence of their prostate cancer after radiotherapy. Early scans can detect recurrence before the cancer progresses to a more advanced stage.
Authors
- Remco J.J. Knol (ORCID: https://orcid.org/0000-0003-1089-2981)
- Marieke L Korbee
- Maurits Wondergem (ORCID: https://orcid.org/0000-0001-8227-9145)
- Daniela E. Oprea‐Lager (ORCID: https://orcid.org/0000-0001-9447-2305)
- Stéphanie van der Pas (ORCID: https://orcid.org/0000-0002-2448-5378)
- Pim J. van Leeuwen (ORCID: https://orcid.org/0000-0002-5531-6104)
- B.H.E. Jansen (ORCID: https://orcid.org/0000-0003-2107-145X)
- Jochem R.N. van der Voort van Zyp
- Wietske I. Luining (ORCID: https://orcid.org/0000-0003-4590-6589)
- André N. Vis (ORCID: https://orcid.org/0000-0003-3419-3368)
- Jakko A. Nieuwenhuijzen (ORCID: https://orcid.org/0000-0002-8977-5501)
- Friso M. van der Zant
- Evelien J E van Altena
Institutions
- Dutch Cancer Society (NL)
- University Medical Center Utrecht (NL)
- Northwest Hospital (US)
- Prostate Cancer UK (GB)
- Amsterdam University Medical Centers (NL)
Publication Details
- Journal
- European Urology Oncology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1016/j.euo.2024.09.015
- Citations
- 16
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 6.70